# P11-4 and Nanosilver Fluoride Varnish in Treatment of White Spot Carious Lesions

> **NCT04929509** · NA · UNKNOWN · sponsor: **Hams Hamed Abdelrahman** · enrollment: 66 (estimated)

## Conditions studied

- White Spot Lesion

## Interventions

- **OTHER:** self-assembling peptide
- **OTHER:** nanosilver fluoride varnish
- **OTHER:** sodium fluoride varnish

## Key facts

- **NCT ID:** NCT04929509
- **Lead sponsor:** Hams Hamed Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-05
- **Primary completion:** 2021-10-05
- **Final completion:** 2022-01-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04929509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04929509, "P11-4 and Nanosilver Fluoride Varnish in Treatment of White Spot Carious Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04929509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*